Dynasil Corporation of America logo

Dynasil Corporation of America (DYSL)

Market Open
10 Aug, 13:30
OTC PINK OTC PINK
$
1. 80
0
0%
$
27.01M Market Cap
- P/E Ratio
- Div Yield
2,000 Volume
0 Eps
$ 1.8
Previous Close
Add Transaction
Day Range
1.8 1.8
Year Range
1.1 1.91
Want to track DYSL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

DYSL trading today higher at $1.8, an increase of 0% from yesterday's close, completing a monthly increase of 0% or $0. Over the past 12 months, DYSL stock gained 42.8571%.
DYSL pays dividends to its shareholders, with the most recent payment made on Mar 15, 2024. The next estimated payment will be in 15 Mar 2024 on Mar 15, 2024 for a total of $0.1.
The last earnings report, released on May 14, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Dynasil Corporation of America has completed 1 stock splits, with the recent split occurring on Nov 01, 1996.
The company's stock is traded on one exchange.

DYSL Chart

People also search for

Realbotix Corp.
$ 0.21
+1.7342%
Luna Innovations Incorporated
$ 1.27
+0.7937%
Marpai Inc.
$ 2.2
0%
Argo Corp.
$ 0.23
-4.1061%
Rocket Doctor AI Inc.
$ 0.41
-1.5886%

Dynasil Corporation of America (DYSL) FAQ

What is the stock price today?

The current price is $1.80.

On which exchange is it traded?

Dynasil Corporation of America is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is DYSL.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 27.01M.

Has Dynasil Corporation of America ever had a stock split?

Dynasil Corporation of America had 1 splits and the recent split was on Nov 01, 1996.

Dynasil Corporation of America Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Peter Sulick CEO
OTC PINK Exchange
268102209 CUSIP
US Country
207 Employees
15 Mar 2024 Last Dividend
1 Nov 1996 Last Split
- IPO Date

Overview

Dynasil Corporation of America is a pioneering company that specializes in the development, marketing, manufacturing, and sale of sophisticated detection, sensing, and analysis technology along with high-quality optical components. With a global footprint that extends across the United States, Asia, Europe, and other international markets, Dynasil has established itself as a leader in its field. Founded in 1960 and based in Newton, Massachusetts, the company operates through three main segments: Optics, Innovation and Development, and Biomedical. Each segment caters to a unique set of applications and industries, ranging from medical and industrial to homeland security/defense. Through its integrated approach that combines direct sales, marketing staff, and strategic partnerships with manufacturer’s representatives and distributors, Dynasil ensures its cutting-edge products and technologies reach a wide array of sectors worldwide.

Products and Services

  • Optics Segment:

    This division of Dynasil supplies synthetic crystals, optical materials, components, and coatings crucial for a variety of devices. The applications for these products span a wide range of sectors such as medical imaging systems, baggage scanners, optical instruments, lasers, analytical instruments, automotive components, semiconductor/electronic devices, spacecraft/aircraft components, and advertising displays. These products find their utility in critical areas including the medical sector, industrial applications, and homeland security/defense initiatives.

  • Innovation and Development Segment:

    Dedicated to the advancement of technology, this segment works on the development of new materials, sensors, and prototype instruments that are capable of detecting or measuring various phenomena such as radiation, light, magnetism, or sound. The technologies developed in this segment find applications in security, medical, and industrial domains, showcasing Dynasil's commitment to innovation and the betterment of these critical sectors.

  • Biomedical Segment:

    This segment focuses on the biomedical sphere, specifically on the development of tissue sealant products. Through its innovations in the biomedical segment, Dynasil aims to contribute to the health sector by offering advanced solutions that aid in medical procedures and healing processes, highlighting the company's diverse expertise and its contribution to medical advancements.

Contact Information

Address: 200 Baker Avenue, #301
Phone: 16176686855